Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 13, 2022, Fuad El-Hibri, Founder and Executive Chairman of the Board of Directors (the "Board") of Emergent BioSolutions Inc. (the "Company"), notified the Company of his retirement and resignation as an officer, director and employee of the Company, effective as of April 1, 2022. Mr. El-Hibri informed the Company that his retirement is not the result of any dispute or disagreement with the Company, its management or the Board. It is expected that Mr. El-Hibri will be available following his retirement as needed on an advisory and consulting basis on terms to be agreed by the Company and Mr. El-Hibri.

Item 7.01. Regulation FD Disclosure.

On January 14, 2022, the Company issued a press release regarding Mr. El-Hibri's retirement, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.

Exhibit No.                                               Description
99.1                          Press release issued     on January     14    , 2022.
101                         Emergent BioSolutions Inc. Current Report on Form 8-K, dated January 13,
                            2022 formatted in XBRL (Extensible Business Reporting Language): Cover
                            Page. The instance document does not appear in the Interactive Data File
                            because its XBRL tags are embedded within the Inline XBRL document.
104                         Cover Page Interactive Data File (formatted as Inline XBRL and contained
                            in Exhibit 101).

© Edgar Online, source Glimpses